E

Elevation Oncology
D

ELEV

0.62300
USD
0.00
(0.61%)
مغلق
حجم التداول
5,273
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
36,831,171
الأخبار

العنوان: Elevation Oncology

القطاع: Healthcare
الصناعة: Biotechnology
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.